Once upon a time a big success for Antisense would have been significant for Opthea - they used to hold a larger fraction of the company, and the two companies had vaguely similar market caps. But now ANP could triple in value and that'd be worth barely $1 million to Opthea - of no real consequence for a company with $30 million in cash and a market cap approaching $1 billion.
More interesting would be if Opthea could now look at some of the other IP assets it inherited from its life as Circadian...
price target, page-21
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.04 |
Change
0.010(0.97%) |
Mkt cap ! $1.280B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.07 | $1.02 | $3.944M | 3.778M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7769 | $1.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 30/01/2025 (20 minute delay) ? |
| OPT (ASX) Chart |